McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan authored an article entitled, “The latest on the gene patenting case Association for Molecular Pathology v. Myriad Genetics” that appears in the October 2012 edition of the Westlaw Journal Intellectual Property. Dr. Noonan examines the arguments presented to the Federal Circuit U.S. Court of Appeals following remand by the U.S. Supreme Court of a case involving the patentability of DNA-level matter and its possible use in treating breast cancer. View the article (subscription required)